Connection
David Bortz to Glutamic Acid
This is a "connection" page, showing publications David Bortz has written about Glutamic Acid.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.829 |
|
|
|
-
Bortz DM, Wu HQ, Schwarcz R, Bruno JP. Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex. Neuropharmacology. 2017 Jul 15; 121:69-78.
Score: 0.507
-
Bortz DM, Upton BA, Mikkelsen JD, Bruno JP. Positive allosteric modulators of the a7 nicotinic acetylcholine receptor potentiate glutamate release in the prefrontal cortex of freely-moving rats. Neuropharmacology. 2016 12; 111:78-91.
Score: 0.485
-
Bortz DM, J?rgensen CV, Mikkelsen JD, Bruno JP. Transient inactivation of the ventral hippocampus in neonatal rats impairs the mesolimbic regulation of prefrontal glutamate release in?adulthood. Neuropharmacology. 2014 Sep; 84:19-30.
Score: 0.412
-
Bortz DM, Mikkelsen JD, Bruno JP. Localized infusions of the partial alpha 7 nicotinic receptor agonist SSR180711 evoke rapid and transient increases in prefrontal glutamate release. Neuroscience. 2013; 255:55-67.
Score: 0.397
-
Pershing ML, Bortz DM, Pocivavsek A, Fredericks PJ, J?rgensen CV, Vunck SA, Leuner B, Schwarcz R, Bruno JP. Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia. Neuropharmacology. 2015 Mar; 90:33-41.
Score: 0.027